Interesting, page-579

Great post.
Bob and others keep taking material salaries, missing milestone dates and have none of their own money in the game.
The money missed by the regulators block could easily be made up by the exec taking 50% of their salaries in shares until the in human trials are proven successful.
When the CEO doesn't buy any shares at $0.011c in the product that he's selling to market there is a massive mixed message.
I know that shareholders have personally discussed this directly with Bob however he seems to find it unattractive.